Food and Drug Administration 510(k) clearance earlier this year.
hospitals but also ASCs and international treatment facilities.”Īccelus is also proud to launch its latest evolution in Adaptive Geometry with its new Toro-L Biplanar Expandable Interbody Fusion System, which received U.S. “With fluoroscopy capabilities and additional procedural uses currently in development at our newly opened R&D lab in Boulder, Colo., this system will provide tremendous value for not only U.S.
“Finally, spine surgeons have a system without the workflow and cost constraints that have prevented their wide-scale adoption of robotics,” said Brad Clayton, Chief Technical Officer for Accelus. The entire system is self-contained in a lightweight 30” x 30” cart, providing a minimal footprint ideal for hospitals and ASCs with efficient set-up and breakdown, as well as integrated cleaning and storage. 1 With its ultra-lightweight, nearfield camera and four-pound robotic arm attached to the surgical bed, the system allows broad tracking of instrumentation while minimizing line-of-sight issues. A recently published study showed the system has a significantly shorter procedure workflow duration while maintaining the same accuracy as the most commonly used robotic platform. Our robotic navigation platform is also changing the game for robotic spine surgery – providing the same accuracy as the most commonly used system but at a fraction of the cost.”Īccelus will launch its Robotic Navigation System, with the company’s LineSider ® Spinal System, during NASS 2021. “While other companies continue to chase footprint via trajectory, Accelus has solved for footprint through our Adaptive Geometry™ technology, as seen in our flagship FlareHawk ® and Toro™-L expandable interbody fusion devices. “Our attendance at NASS underscores our commitment to partnering with spine surgeons to increase the adoption, efficiency and success of their minimally invasive surgeries,” said Chris Walsh, CEO and Co-Founder of Accelus.
Accelus will be located in Booth #1439 with private meetings and demonstrations occurring in Exhibitor Suite #1029. 27, 2021 (GLOBE NEWSWIRE) - Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that it will attend the 36 th Annual North American Spine Society (“NASS”) Meeting held September 29 through October 2 at the Boston Convention and Exhibition Center.